Transcriptional activation of the human epidermal growth factor receptor promoter by human p53.
about
The transcription factor p53: not a repressor, solely an activatorMolecular cloning and characterization of a transcription regulator with homology to GC-binding factorEmerging Non-Canonical Functions and Regulation by p53: p53 and StemnessIntegrity of the N-terminal transcription domain of p53 is required for mutant p53 interference with drug-induced apoptosisThe Y-box-binding protein, YB1, is a potential negative regulator of the p53 tumor suppressorActivation of the p53-p21(Cip1) pathway is required for CDK2 activation and S-phase entry in primary rat hepatocytesMutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers.Notch-1 regulates transcription of the epidermal growth factor receptor through p53.Chromatin immunoprecipitation-based screen to identify functional genomic binding sites for sequence-specific transactivators.Mutant p53 gain-of-function in cancer.Whole genome expression profiling shows that BRG1 transcriptionally regulates UV inducible genes and other novel targets in human cellsEpidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neckMutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cellsTP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma.Upregulation of the mitochondrial transport protein, Tim50, by mutant p53 contributes to cell growth and chemoresistanceExpression of p53 target genes in the early phase of long-term potentiation in the rat hippocampal CA1 areaTIEG1 inhibits breast cancer invasion and metastasis by inhibition of epidermal growth factor receptor (EGFR) transcription and the EGFR signaling pathway.Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.Transcriptional activities of mutant p53: when mutations are more than a loss.Mutant p53: one name, many proteins.A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracilTranscription regulation by mutant p53.Mutant p53: an oncogenic transcription factor.Mutant p53-R273H gains new function in sustained activation of EGFR signaling via suppressing miR-27a expressionStructural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.Loss of p53 induces epidermal growth factor receptor promoter activity in normal human keratinocytesPTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway.The consequence of oncomorphic TP53 mutations in ovarian cancer.TP53 mutation, mitochondria and cancer.Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway.NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme.Role of p53 in Cell Death and Human Cancers.Transcriptional down-regulation of epidermal growth factor (EGF) receptors by nerve growth factor (NGF) in PC12 cells.Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 ("Iressa")Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches.Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53.Activation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The "Rotation Model".p53 mutants induce transcription of NF-κB2 in H1299 cells through CBP and STAT binding on the NF-κB2 promoter and gain of function activity.
P2860
Q24273295-35805873-C296-44E0-90F2-0801DDC6B5D0Q24323630-917660C5-FB48-466F-B480-664BB161DA22Q28077156-B1984873-EFF8-46E8-889C-7B055AAE5B4EQ28345092-93E5E905-F336-42EB-B5AA-EA2D221BE1FFQ28564441-873161A3-188E-47C5-BDFD-B5FF57A49D23Q28580587-6802984A-9860-461D-B873-1ECEE23A9996Q30354662-E1869844-8A16-4491-9B0E-3AA33B2988B7Q30435514-90573E16-DAED-4B04-B5E2-2FD78459FF0BQ33226324-FCB3D1EF-7145-43B1-9DFB-F785599079D6Q33687048-EFF8CFF1-B0FD-43FD-A9CE-11ED471C4EFDQ34089949-68205592-B9D0-4017-B028-8303E8E2F090Q34159125-09AD9687-D253-425F-9A9F-CC55523A00B7Q34480997-F1885856-7640-405C-9DBE-1CE3F8A49A21Q34775855-04B3DE71-F3FE-4939-9403-0CAB4E6419C8Q35086367-816929D3-ADFB-48B4-BC18-5036A1828BD6Q35124631-B1CC11BD-5F7E-4856-B511-A36BC1202707Q35665493-FAE3E6AD-2E7B-4E28-B986-707BA2045EB1Q35673572-BD833161-49A8-4B7B-A394-5899ACC5F8DAQ35902152-1A500054-529C-4277-9113-AF4990931EFAQ36070574-851A53F7-704B-43DA-8899-5093C2847F8EQ36619294-56977708-4173-4E47-A104-14120FD7BC99Q36777349-E7A22027-95AA-4EF5-ABE9-5A32E4F04F97Q36777355-FA384538-9C0E-4759-A959-6EDB75276FE6Q36812554-7D6B1105-0A23-4FB8-9111-7E37AC195725Q36941044-29CF9346-4E67-40AC-A3E3-AEEEBA1B0E85Q36946749-9C6F8540-27CE-4425-8467-107A1D0B67E4Q36947098-01329AC0-FA53-4CD2-9F96-1C1F13F3A2E5Q37143062-C131063F-D808-4518-A28D-72D8AFECF46DQ37225303-45CF2A22-D80B-427E-B783-DA1819DAD500Q37266021-17051B22-A89F-4B18-B1FA-E716FF7A6F4BQ37426890-C612B4F4-8AB4-4A98-A9AF-56BA4B0DDAA1Q37687793-F05AD2A7-9911-45A7-B77D-F948B1E11009Q38112074-BD7C398F-BB60-4E84-9DA0-95A22E82AD80Q38161342-6D8DBA35-369D-4D07-98AC-A06744129955Q38235510-546CDDAC-7E1C-497F-B8A7-5A3B0DD9D783Q38283276-CCE1F367-7C5F-4F88-9F16-A221B04BFF76Q38296572-DDCD407F-F65F-4847-AF22-9FE1C405FA57Q39005896-359F48AE-044F-4564-9CBF-914B6FD1805CQ39346046-3AACA990-A10D-4012-ACDC-A8168116F77EQ39422471-AFEE514E-4362-4C7C-BCB1-446337F93FD7
P2860
Transcriptional activation of the human epidermal growth factor receptor promoter by human p53.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Transcriptional activation of ...... eceptor promoter by human p53.
@en
type
label
Transcriptional activation of ...... eceptor promoter by human p53.
@en
prefLabel
Transcriptional activation of ...... eceptor promoter by human p53.
@en
P2093
P2860
P356
P1476
Transcriptional activation of ...... eceptor promoter by human p53.
@en
P2093
C V Shivakumar
J E Bigger
J H Ludes-Meyers
M A Subler
P2860
P304
P356
10.1128/MCB.16.11.6009
P407
P577
1996-11-01T00:00:00Z